Published in Oncology Business Week, October 24th, 2004
Under this agreement, Mercy Women's Center will provide Power3 Medical up to 600 blood serum samples from normal subjects and subjects with various stages of breast cancer.
According to Hollingsworth, "Such a test would revolutionize screening and diagnosis of breast cancer, yet very little attention has been...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.